Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
35.6 USD | -0.24% | -1.39% | +22.46% |
Mar. 07 | Kewaunee Scientific Shares Fall After Company Posts Lower Fiscal Q3 Net Sales | MT |
Mar. 06 | Earnings Flash (KEQU) KEWAUNEE SCIENTIFIC CORPORATION Posts Q3 Revenue $46.8M | MT |
Financials (USD)
Sales 2022 | 169M | Sales 2023 | 219M | Capitalization | 45.99M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | - | EV / Sales 2022 | 0.44 x |
Net Debt 2022 | 34.36M | Net Debt 2023 | 33.62M | EV / Sales 2023 | 0.36 x |
P/E ratio 2022 |
-6.48
x | P/E ratio 2023 |
65
x | Employees | 982 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.33% |
1 day | +0.78% | ||
1 week | -0.04% | ||
Current month | -0.04% | ||
1 month | -1.15% | ||
3 months | +25.60% | ||
6 months | +94.47% | ||
Current year | +22.76% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Hull
CEO | Chief Executive Officer | 48 | 15-10-31 |
Donald Gardner
DFI | Director of Finance/CFO | 45 | 19-04-28 |
Mandar Ranade
CTO | Chief Tech/Sci/R&D Officer | 50 | 19-12-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Rhind
CHM | Chairman | 61 | 08-03-31 |
Donald Shaw
BRD | Director/Board Member | 73 | 13-05-31 |
Keith Gehl
BRD | Director/Board Member | 65 | 15-04-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 35.6 | -0.24% | 1 573 |
24-05-07 | 35.68 | +0.78% | 1,714 |
24-05-06 | 35.41 | +0.65% | 4,993 |
24-05-03 | 35.18 | +1.50% | 2,696 |
24-05-02 | 34.66 | -3.99% | 3,078 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+22.76% | 103M | |
+11.34% | 7.4B | |
+5.81% | 2.98B | |
+3.58% | 2.94B | |
+6.69% | 2.11B | |
+6.06% | 1.42B | |
-6.07% | 1.46B | |
-19.24% | 470M | |
+1.89% | 444M | |
-18.24% | 363M |
- Stock Market
- Equities
- KEQU Stock